Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis

Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis

Background: Localized Gleason Grade Group 5 (GG5) prostate cancer has a poor prognosis and is associated with a higher risk of treatment failure, metastases, and death. Treatment intensification with the addition of a brachytherapy (BT) boost to external beam radiation (EBRT) maximizes local control...

Full description

Bibliographic Details
Main Authors: Terence Tang, Stephanie Gulstene, Eric McArthur, Andrew Warner, Gabriel Boldt, Vikram Velker, David D'Souza, Glenn Bauman, Lucas C. Mendez
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Prostate cancer
Gleason Grade Group 5
External beam radiotherapy
Brachytherapy boost
Survival outcome
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630822000945

Internet

http://www.sciencedirect.com/science/article/pii/S2405630822000945

Similar Items